Background This systematic review reports on outcomes and toxicities following stereotactic
radiosurgery (SRS) for non-functioning pituitary adenomas (NFAs) and presents consensus …

Accumulated studies have not provided conclusive evidence in regards to the comparative
efficacy and safety of fractionated stereotactic radiotherapy and stereotactic radiosurgery for …

OBJECTIVE A systematic review was performed to provide objective evidence on the use of
stereotactic radiosurgery (SRS) in the management of secretory pituitary adenomas and …

Objective Single fraction stereotactic radiosurgery (SRS) is a common adjuvant therapy for
hormonally active pituitary adenomas when surgical resection fails to control tumor growth …

Non-functioning pituitary adenomas are primarily a surgically managed pathology, but
recurrence or regrowth is not uncommon. Previous large series have retrospectively …

Pituitary radiotherapy (RT) has undergone important progress in the last decades due to the
development of new stereotactic techniques which provide more precise tumour targeting …

Objective We describe the use of fractionated stereotactic radiotherapy (FSRT) for the
treatment of large, invasive, nonfunctioning pituitary adenomas (NFPAs). FSRT is frequently …

BACKGROUND: Despite the advancement of microsurgical and endoscopic techniques,
some nonfunctioning pituitary adenomas (NFPAs) can be difficult to cure. Tumor recurrence …

METHODS: We evaluated the management outcomes of Gamma Knife radiosurgery in 125
patients with NFPAs over an interval of 22 years. The median patient age was 54 years …

Radiotherapy (RT) is frequently employed in patients with residual or recurrent pituitary
adenoma with excellent rates of tumor control and remission of hormonal hypersecretion …